永和智控(002795.SZ):擬收購昆明醫科腫瘤醫院90%的註冊資本
格隆匯 7 月 6日丨永和智控(002795.SZ)公佈,公司全資子公司成都永和成醫療科技有限公司(“成都永和成”)於2020年7月6日與龍巖市長峯網絡科技合夥企業(有限合夥)(“龍巖長峯”)簽署了《股權收購框架協議》,成都永和成擬以現金交易方式收購龍巖長峯持有的昆明醫科腫瘤醫院有限公司(“昆明醫科”或“標的公司”)9000萬元股權,佔昆明醫科註冊資本的90%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.